Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	607	620	419	365	526	301
Market Cap Growth	44.31%	47.80%	15.00%	-30.72%	74.57%	74.57%
Enterprise Value	498	496	285	189	556	353
Last Close Price	3.19	3.27	2.50	2.33	3.89	3.55
PS Ratio	94.35	100.41	23.11	9.34	47.89	43.60
PB Ratio	7.69	6.36	3.95	2.66	3.11	2.96
P/TBV Ratio	7.64	6.36	3.95	2.66	3.11	-
EV/Sales Ratio	77.77	80.32	15.69	4.85	50.59	51.00
Debt / Equity Ratio	0.07	0.06	0.08	0.09	0.11	0.22
Asset Turnover	0.05	0.05	0.11	0.20	0.06	0.06
Quick Ratio	6.01	8.03	5.71	4.51	13.92	13.06
Current Ratio	6.01	8.15	5.87	4.60	14.32	13.39
Return on Equity (ROE)	-79.02%	-68.76%	-59.99%	-45.35%	-56.19%	-72.97%
Return on Assets (ROA)	-31.58%	-33.36%	-28.70%	-19.76%	-26.22%	-29.51%
Return on Capital (ROIC)	-40.69%	-42.21%	-36.93%	-23.40%	-28.63%	-32.60%
Earnings Yield	-12.65%	-11.28%	-17.38%	-19.05%	-14.49%	-21.15%
FCF Yield	-9.77%	-10.50%	-20.74%	-9.84%	-12.99%	-17.14%
Buyback Yield / Dilution	-11.76%	-11.84%	-9.95%	-42.07%	-40.10%	-32.83%

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q